Rhenman & Partners Asset Management AB - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$4,071,000
-11.7%
150,0000.0%0.44%
-9.7%
Q2 2023$4,611,000
-23.0%
150,000
-9.1%
0.49%
-26.1%
Q1 2023$5,989,500
-29.5%
165,000
-23.3%
0.66%
-25.7%
Q4 2022$8,496,800
-6.6%
215,0000.0%0.89%
-7.0%
Q3 2022$9,099,000
+44.3%
215,000
+43.3%
0.95%
+33.1%
Q2 2022$6,306,000
+11.2%
150,000
+15.4%
0.72%
+81.3%
Q1 2021$5,671,000
-54.7%
130,000
-48.0%
0.40%
-61.3%
Q4 2020$12,513,000250,0001.02%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2022
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders